its cholesterol-lowering effect in 40 patients with heterozygous familial hypercholesterolaemia was more pronounced ( an ldl-cholesterol reduction of 43 % ) than that of cholestyramine monotherapy in a matched group of 20 patients ( 30 % reduction ) .
C0008377
cholesterol
C0023824
ldl-cholesterol